Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

SBC Medical Group Holdings (SBC) Enterprise Value (2023 - 2025)

Historic Enterprise Value for Medical Group Holdings (SBC) over the last 3 years, with Q3 2025 value amounting to -$127.4 million.

  • Medical Group Holdings' Enterprise Value rose 693.68% to -$127.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$127.4 million, marking a year-over-year increase of 693.68%. This contributed to the annual value of -$125.1 million for FY2024, which is 2343.77% down from last year.
  • As of Q3 2025, Medical Group Holdings' Enterprise Value stood at -$127.4 million, which was up 693.68% from -$152.7 million recorded in Q2 2025.
  • Medical Group Holdings' 5-year Enterprise Value high stood at -$217348.0 for Q1 2023, and its period low was -$152.7 million during Q2 2025.
  • Over the past 3 years, Medical Group Holdings' median Enterprise Value value was -$113.3 million (recorded in 2023), while the average stood at -$78.0 million.
  • Within the past 5 years, the most significant YoY rise in Medical Group Holdings' Enterprise Value was 693.68% (2025), while the steepest drop was 1092516.99% (2025).
  • Quarter analysis of 3 years shows Medical Group Holdings' Enterprise Value stood at -$101.4 million in 2023, then fell by 23.44% to -$125.1 million in 2024, then fell by 1.78% to -$127.4 million in 2025.
  • Its Enterprise Value was -$127.4 million in Q3 2025, compared to -$152.7 million in Q2 2025 and -$132.2 million in Q1 2025.